Ines Zulantay
Overview
Explore the profile of Ines Zulantay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liempi D, Zulantay I, Varela N, Canals M, Guevara A, Poulsen N, et al.
Microorganisms
. 2024 Feb;
12(2).
PMID: 38399653
The objective of this study was to compare, by qPCR, the circulating blood parasite load of in the buffy coat, and in whole blood mixed with boiled and unboiled guanidine...
2.
Apt W, Zulantay I, Salas P
Rev Med Chil
. 2023 Oct;
150(12):1689-1690.
PMID: 37906792
No abstract available.
3.
Zulantay I, Munoz G, Liempi D, Rozas T, Manneschi M, Munoz-San Martin C, et al.
Pathogens
. 2022 Jul;
11(7).
PMID: 35890030
Chagas disease (ChD) is a vector zoonosis native to the American continent caused by the protozoan parasite ; the biological vectors are multiple species of hematophagous insects of the family...
4.
Apt W, Llancaqueo M, Zulantay I, Canals M, Kara S, Arribada A, et al.
J Glob Antimicrob Resist
. 2021 Sep;
27:160-166.
PMID: 34496323
Objectives: This study aimed to describe the electrocardiographic and echocardiographic status of chronic Chagas disease (cChD) patients treated with nifurtimox. Methods: An observational study was performed in 146 cChD patients...
5.
Ayala S, Alvarado S, Caceres D, Zulantay I, Canals M
Rev Med Chil
. 2019 Dec;
147(6):683-692.
PMID: 31859820
Background: Reproductive number (R0)-maps estimate risk zones of vector-borne diseases and geographical distribution changes under climate change. Aim: To map R0 aiming to estimate the epidemiological risk of Chagas disease...
6.
Apt W, Carrasco D, Fuentealba C, Canals M, Munoz G, Saavedra M, et al.
Acta Trop
. 2019 Sep;
200:105167.
PMID: 31513762
It is not currently known which individuals with chronic Chagas disease (ChD) will develop cardiopathy in a determined period and which will be maintained asymptomatic with normal routine laboratory tests...
7.
Vergara C, Munoz G, Martinez G, Apt W, Zulantay I
PLoS One
. 2019 Aug;
14(8):e0221100.
PMID: 31433828
Chagas disease, a vector-borne parasitosis caused by Trypanosoma cruzi, is endemic to Latin America and has spread to other countries due to immigration of infected persons. It is estimated that...
8.
Munoz G, Vergara C, Martinez G, Apt W, Zulantay I
Korean J Parasitol
. 2019 Mar;
57(1):39-41.
PMID: 30840798
In the indeterminate chronic period of Chagas disease (ChD) the treatment has not been conclusive, because the serological negativization requires many years. This study aims to evaluate the efficacy of...
9.
Sguassero Y, Roberts K, Harvey G, Comande D, Ciapponi A, Cuesta C, et al.
Int J Infect Dis
. 2018 Jun;
73:93-101.
PMID: 29879524
Objective: To determine the course of serological tests in subjects with chronic Trypanosoma cruzi infection treated with anti-trypanosomal drugs. Methods: A systematic review and meta-analysis was conducted using individual participant...
10.
Munoz-San Martin C, Zulantay I, Saavedra M, Fuentealba C, Munoz G, Apt W
Acta Trop
. 2018 May;
185:280-284.
PMID: 29746871
Chagas disease is a major public health problem in Latin America and has spread to other countries due to immigration of infected persons. 10-30% of patients with chronic Chagas disease...